Creyon Bio is the latest company to launch with artificial intelligence technology for drug R&D. The startup claims it's technology can provide sufficient safety and toxicity to enable a therapy to bypass the animal research currently needed before clinical trials.
Hear from healthcare executives such as CVS Kidney Care President Lisa Rometty, Komodo Health CEO Dr. Arif Nathoo, and McKesson Ventures Partner Michelle Snyder on how they're thinking about digital transformation in healthcare in a series of interviews at ViVE.
While the healthcare industry's digital transformation continues pushing forward — accelerated, in part, by growing adoption of telehealth — we're also seeing the effects of a stronger digital foundation for the future of healthcare.
Throughout this pandemic, out of necessity, we changed the way we practice medicine. It is my belief that we can use these new practices to create a better system that provides more support and focus on nurse well-being, career development and collaboration, without sacrificing patient care.
By Michael Schroeder Sunday, March 13, 2022 10:00 AM
In a sit-down interview, Roy Schoenberg said the fixation on consumer behavior around telehealth misses the bigger story. He thinks provider adoption and integration of telehealth will drive greater use, setting Amwell apart from direct-to-consumer telehealth providers like Teladoc.
Creyon Bio is the latest company to launch with artificial intelligence technology for drug R&D. The startup claims it's technology can provide sufficient safety and toxicity to enable a therapy to bypass the animal research currently needed before clinical trials.
By Shawna Koch Mishael Sunday, March 13, 2022 9:00 AM
New Fast Healthcare Interoperability Resources (FHIR) regulations promote innovation, interoperability and the free flow of data. Americans have demanded more transparency in healthcare for decades, and finally, there are governing bodies in place to support it.
MedCity INVEST 2022 at The Ritz Carlton Chicago is a 3 day gathering with numerous opportunities for in-person networking and learning around the latest technologies and investment trends from VCs and successful entrepreneurs.
No comments